Binay Shah, Co-Founder, President and CEO at Binaytara, shared on LinkedIn:
”One of the things I’m most excited about with the Binaytara National Summit on Hematologic Cancers is creating opportunities for researchers to do more than simply present their work.
Opportunities to compete for multiple $25,000 and $50,000 awards, present their research at a national conference, and most importantly, receive real-time feedback and engage directly with leading clinician-scientists in hematology.
If you have research that deserves a larger audience, I encourage you to submit it.
Please share with your colleagues who may have work to submit and need funding for their research. ”
Navneet Majhail, Physician-in-Chief of Blood Cancers at Sarah Cannon, shared Binay Shah‘s post adding:
”There’s just 48 hours left to submit your abstract to the Binaytara National Summit on Hematologic Cancers. Submit by August 15, 2026 for the chance to earn one of multiple $25,000 or $50,000 awards, present at a national conference, and get real-time feedback on your work from top clinician-scientists in the field of hematology.
Binay Shah was recognized among OncoDaily’s The 100 Most Influential People in Oncology in 2025, highlighting his contributions to the field of oncology.
Nominations for 100 Influential People in Oncology 2026 are now open, recognizing leaders, researchers, clinicians, innovators, advocates, and other individuals making a meaningful impact on oncology and cancer care.
Don’t miss the opportunity to nominate yourself, a colleague, or someone whose contributions deserve to be recognized.
Submit your nomination by September 15: 100 Influential People in Oncology 2026 – Nominations are Open!
Other articles featuring Binay Shah on OncoDaily.